Identification of a novel effector domain of BIN1 for cancer suppression

Journal of Cellular Biochemistry

Volumn 112, Issue 10, 2011, Pages 2992-3001

  Lundgaard, Greta L ^a,f   Daniels, Natae E ^a,g   Pyndiah, Slovénie ^b,h   Cassimere, Erica K ^b,c,i   Ahmed, Kazi M ^a,j   Rodrigue, Amélie ^c,k   Kihara, Daisuke ^d,e   Post, Carol B ^a   Sakamuro, Daitoku ^a,b,c  

^a PURDUE UNIVERSITY   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c PURDUE UNIVERSITY   (United States)

^d PURDUE UNIVERSITY   (United States)

^e Purdue University   (United States)

^f GILEAD SCIENCES   (United States)

^g Ernest Orlando Lawrence Berkeley National Laboratory ^*  (United States)

^h SAINT LOUIS HOSPITAL   (France)

ⁱ UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^j LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^k UNIVERSITÉ LAVAL   (Canada)

more..

Author keywords

BIN1; c MYC; cancer suppression; cytoplasmic localization; limited proteolysis

Indexed keywords

ADAPTOR PROTEIN; AMINO ACID; BRIDGING INTEGRATOR 1; TRYPSIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CANCER INHIBITION; CYTOPLASM; GENE ACTIVITY; HUMAN; HUMAN CELL; MASS SPECTROMETRY; MYC INDEPENDENT EFFECTOR DOMAIN; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN STRUCTURE; TUMOR GROWTH;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CELL LINE; HUMANS; MASS SPECTROMETRY; NEOPLASMS; NUCLEAR PROTEINS; PROTEIN ISOFORMS; PROTEIN STRUCTURE, TERTIARY; TRYPSIN; TUMOR SUPPRESSOR PROTEINS;

EID: 80053201482     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.23222     Document Type: Article

References (30)

1. Baker SJ, Markowitz S, Fearon ER, Willson JK, Vogelstein B,. 1990. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249 (4971): 912-915.
2. 2-terminal BRCA1 RING finger domain. J Biol Chem 273 (14): 7795-7799. (Pubitemid 28168821)
3. Casal E, Federici L, Zhang W, Fernandez-Recio J, Priego EM, Miguel RN, DuHadaway JB, Prendergast GC, Luisi BF, Laue ED,. 2006. The crystal structure of the BAR domain from human BIN1/amphiphysin II and its implications for molecular recognition. Biochemistry 45 (43): 12917-12928. (Pubitemid 44763415)
4. Cassimere EK, Pyndiah S, Sakamuro D,. 2009. The c-MYC-interacting proapoptotic tumor suppressor BIN1 is a transcriptional target for E2F1 in response to DNA damage. Cell Death Differ 16 (12): 1641-1653.
5. DuHadaway JB, Sakamuro D, Ewert DL, Prendergast GC,. 2001. BIN1 mediates apoptosis by c-MYC in transformed primary cells. Cancer Res 61 (7): 3151-3156. (Pubitemid 32691968)
6. Elliott K, Sakamuro D, Basu A, Du W, Wunner W, Staller P, Gaubatz S, Zhang H, Prochownik E, Eilers M, Prendergast GC,. 1999. BIN1 functionally interacts with c-MYC and inhibits cell proliferation via multiple mechanisms. Oncogene 18 (24): 3564-3573. (Pubitemid 29322381)
7. Elliott K, Ge K, Du W, Prendergast GC,. 2000. The c-Myc-interacting adaptor protein Bin1 activates a caspase-independent cell death program. Oncogene 19 (41): 4669-4684.
8. Fontana A, Zambonin M, De Filippis V, Bosco M, Polverino de Laureto P,. 1995. Limited proteolysis of cytochrome c in trifluoroethanol. FEBS Lett 362 (3): 266-270.
9. Fontana A, Polverino de Laureto P, De Filippis V, Scaramella E, Zambonin M,. 1997. Probing the partly folded states of proteins by limited proteolysis. Fold Des 2 (2): R17-R26. (Pubitemid 127740454)
10. Ge K, DuHadaway J, Du W, Herlyn M, Rodeck U, Prendergast GC,. 1999. Mechanism for elimination of a tumor suppressor: Aberrant splicing of a brain-specific exon causes loss of function of BIN1 in melanoma. Proc Natl Acad Sci USA 96 (17): 9689-9694. (Pubitemid 29398793)
11. Ge K, Minhas F, DuHadaway J, Mao NC, Wilson D, Buccafusca R, Sakamuro D, Nelson P, Malkowicz SB, Tomaszewski J, Prendergast GC,. 2000. Loss of heterozygosity and tumor suppressor activity of Bin1 in prostate carcinoma. Int J Cancer 86: 155-161. (Pubitemid 30180808)
12. Habermann B,. 2004. The BAR-domain family of proteins: A case of bending and binding? EMBO Rep 5 (3): 250-255. (Pubitemid 38500103)
13. Hogue CW,. 1997. Cn3D: A new generation of three-dimensional molecular structure viewer. Trends Biochem Sci 22 (8): 314-316. (Pubitemid 27327090)
14. Kamath N, Karwowska-Desaulniers P, Pflum MK,. 2006. Limited proteolysis of human histone deacetylase 1. BMC Biochem 7: 22.
15. Kameshita I, Matsuda M, Nishikimi M, Ushiro H, Shizuta Y,. 1986. Reconstitution and poly(ADP-ribosyl)ation of proteolytically fragmented poly(ADP-ribose) synthetase. J Biol Chem 261 (8): 3863-3868.
16. Kaur H, Raghava GP,. 2003a. Prediction of beta-turns in proteins from multiple alignment using neural network. Protein Sci 12 (3): 627-634. (Pubitemid 36241119)
17. Kaur H, Raghava GP,. 2003b. A neural-network based method for prediction of gamma-turns in proteins from multiple sequence alignment. Protein Sci 12 (5): 923-929. (Pubitemid 36505427)
18. Kinney EL, Tanida S, Rodrigue AA, Johnson JK, Tompkins VS, Sakamuro D,. 2008. Adenovirus E1A oncoprotein liberates c-MYC activity to promote cell proliferation through abating BIN1 expression via an Rb/E2F1-dependent mechanism. J Cell Physiol 216 (3): 621-631.
19. Lupas A, Van Dyke M, Stock J,. 1991. Predicting Coiled Coils from Protein Sequences. Science 252 (5010): 1162-1164. (Pubitemid 21917026)
20. McDonnell AV, Jiang T, Keating AE, Berger B,. 2006. Paircoil2: Improved prediction of coiled coils from sequence. Bioinformatics 22 (3): 356-358. (Pubitemid 43205384)
21. McGuffin LJ, Bryson K, Jones DT,. 2000. The PSIPRED protein structure prediction server. Bioinformatics 16 (4): 404-405. (Pubitemid 30417087)
22. Meyer N, Penn LZ,. 2008. Reflecting on 25 years with c-MYC. Nat Rev Cancer 8 (12): 976-999.
23. Pineda-Lucena A, Ho CS, Mao DY, Sheng Y, Laister RC, Muhandiram R, Lu Y, Seet BT, Katz S, Szyperski T, Penn LZ, Arrowsmith CH,. 2005. A structure-based model of the c-MYC/BIN1 protein interaction shows alternative splicing of BIN1 and c-MYC phosphorylation are key binding determinants. J Mol Biol 351 (1): 182-194. (Pubitemid 40967064)
24. Prendergast GC, Muller AJ, Ramalingam A, Chang MY,. 2009. BAR the door: Cancer suppression by amphiphysin-like genes. Biochim Biophys Acta 1795 (1): 25-36.
25. Pyndiah S, Tanida S, Ahmed KM, Cassimere EK, Choe C, Sakamuro D,. 2011. c-MYC suppresses BIN1 to release poly(ADP-ribose) polymerase 1: A mechanism by which cancer cells acquire cisplatin resistance. Sci Signal 4: ra19.
26. Sakamuro D, Elliott KJ, Wechsler-Reya R, Prendergast GC,. 1996. BIN1 is a novel MYC-interacting protein with features of a tumour suppressor. Nat Genet 14 (1): 69-77. (Pubitemid 26301549)
27. Sakamuro D, Prendergast GC,. 1999. New MYC-interacting proteins: A second MYC network emerges. Oncogene 18 (19): 2942-2954. (Pubitemid 29276535)
28. Wechsler-Reya R, Sakamuro D, Zhang J, DuHadaway J, Prendergast GC,. 1997. Structural analysis of the human BIN1 gene. Evidence for tissue-specific transcriptional regulation and alternate RNA splicing. J Biol Chem 272 (50): 31453-31458. (Pubitemid 28013284)
29. Wechsler-Reya R, Elliott KJ, Prendergast GC,. 1998. A role for the putative tumor suppressor BIN1 in muscle cell differentiation. Mol Cell Biol 18 (1): 566-575. (Pubitemid 28021067)
30. Wu S, Zhang Y,. 2007. LOMETS: A local meta-threading-server for protein structure prediction. Nucleic Acids Res 35 (10): 3375-3382. (Pubitemid 47073600)